Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online dostop:https://www.rpcardio.com/jour/article/view/1769
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki